Generic Actonel

A patent currently prevents any generic Actonel from being manufactured in the United States. So-called generic versions may be available on the Internet, but the safety of these drugs is questionable. Generic Actonel is expected to become available in 2012, when the patent expires, although other circumstances (such as lawsuits) could delay this.

Generic Actonel: An Overview

Actonel® (risedronate sodium) is a prescription medication used to treat both Paget's disease and osteoporosis. It is part of a group of medications known as bisphosphonates.
 
Actonel is made by Procter and Gamble Pharmaceuticals, Inc. and sanofi-aventis. It is currently under the protection of a patent that prevents any generic Actonel from being manufactured in the United States. Yet if you search the Internet for "generic Actonel," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Actonel may be available from another country, but there is really no way of knowing if you are getting genuine Actonel or not. You should not buy any so-called generic Actonel until an approved version is available.
 

When Will Generic Actonel Be Available?

The first patent for Actonel currently expires in May 2012. This patent was originally set to expire earlier, but the manufacturer was granted an extension in return for performing much-needed pediatric studies. May 2012 is the earliest predictable date that a generic version of the drug could become available. However, other circumstances could come up to extend or shorten the exclusivity period. This includes such things as other patents for specific Actonel uses or lawsuits. Once the patent expires, several companies will likely begin manufacturing generic Actonel.
 
(Generic Actonel Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation